Fig. 1.

*Cumulative incidence of arterial thromboembolism (composite of myocardial infarction and ischemic stroke) in patients with cancer compared to matched control patients (left panel) and when stratified by cancer stage at the time of cancer diagnosis (right panel). Competing risk survival statistics were used to calculate incidence. Dashed lines are used to indicate 95% confidence intervals. Reprinted from Navi et al., J Am Coll Cardiol 2017;70(8):926–38, with permission from Elsevier.